![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:SLC35F5-ACTR3 (FusionGDB2 ID:HG80255TG10096) |
Fusion Gene Summary for SLC35F5-ACTR3 |
![]() |
Fusion gene information | Fusion gene name: SLC35F5-ACTR3 | Fusion gene ID: hg80255tg10096 | Hgene | Tgene | Gene symbol | SLC35F5 | ACTR3 | Gene ID | 80255 | 10096 |
Gene name | solute carrier family 35 member F5 | actin related protein 3 | |
Synonyms | - | ARP3 | |
Cytomap | ('SLC35F5')('ACTR3') 2q14.1 | 2q14.1 | |
Type of gene | protein-coding | protein-coding | |
Description | solute carrier family 35 member F5HCV NS5A-transactivated protein 3hepatitis C virus NS5A-transactivated protein 3 | actin-related protein 3ARP3 actin related protein 3 homologactin-like protein 3 | |
Modification date | 20200313 | 20200327 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000245680, ENST00000409342, ENST00000470204, | ||
Fusion gene scores | * DoF score | 5 X 5 X 3=75 | 16 X 13 X 7=1456 |
# samples | 5 | 17 | |
** MAII score | log2(5/75*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(17/1456*10)=-3.098403704061 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: SLC35F5 [Title/Abstract] AND ACTR3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | SLC35F5(114512741)-ACTR3(114697535), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | SLC35F5-ACTR3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. SLC35F5-ACTR3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. SLC35F5-ACTR3 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. SLC35F5-ACTR3 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | ACTR3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation | 11741539|17220302 |
Tgene | ACTR3 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 17220302 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-D7-6527 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + |
Top |
Fusion Gene ORF analysis for SLC35F5-ACTR3 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000245680 | ENST00000263238 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + |
Frame-shift | ENST00000245680 | ENST00000535589 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + |
Frame-shift | ENST00000245680 | ENST00000536059 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + |
In-frame | ENST00000409342 | ENST00000263238 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + |
In-frame | ENST00000409342 | ENST00000535589 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + |
In-frame | ENST00000409342 | ENST00000536059 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + |
intron-3CDS | ENST00000470204 | ENST00000263238 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + |
intron-3CDS | ENST00000470204 | ENST00000535589 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + |
intron-3CDS | ENST00000470204 | ENST00000536059 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000409342 | SLC35F5 | chr2 | 114512741 | - | ENST00000263238 | ACTR3 | chr2 | 114697535 | + | 6857 | 999 | 732 | 1715 | 327 |
ENST00000409342 | SLC35F5 | chr2 | 114512741 | - | ENST00000536059 | ACTR3 | chr2 | 114697535 | + | 1831 | 999 | 732 | 1715 | 327 |
ENST00000409342 | SLC35F5 | chr2 | 114512741 | - | ENST00000535589 | ACTR3 | chr2 | 114697535 | + | 1852 | 999 | 732 | 1715 | 327 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000409342 | ENST00000263238 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + | 4.94E-05 | 0.99995065 |
ENST00000409342 | ENST00000536059 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + | 0.000430381 | 0.9995696 |
ENST00000409342 | ENST00000535589 | SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + | 0.000410823 | 0.99958915 |
Top |
Fusion Genomic Features for SLC35F5-ACTR3 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + | 1.64E-09 | 1 |
SLC35F5 | chr2 | 114512741 | - | ACTR3 | chr2 | 114697535 | + | 1.64E-09 | 1 |
![]() |
![]() |
![]() |
![]() |
Top |
Fusion Protein Features for SLC35F5-ACTR3 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:114512741/chr2:114697535) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 69_89 | 91 | 1176.3333333333333 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 371_374 | 91 | 1176.3333333333333 | Compositional bias | Note=Poly-Leu |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 252_316 | 91 | 1176.3333333333333 | Domain | Note=EamA |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 101_121 | 91 | 1176.3333333333333 | Transmembrane | Helical |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 243_263 | 91 | 1176.3333333333333 | Transmembrane | Helical |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 268_288 | 91 | 1176.3333333333333 | Transmembrane | Helical |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 296_316 | 91 | 1176.3333333333333 | Transmembrane | Helical |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 327_347 | 91 | 1176.3333333333333 | Transmembrane | Helical |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 361_381 | 91 | 1176.3333333333333 | Transmembrane | Helical |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 395_415 | 91 | 1176.3333333333333 | Transmembrane | Helical |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 420_440 | 91 | 1176.3333333333333 | Transmembrane | Helical |
Hgene | SLC35F5 | chr2:114512741 | chr2:114697535 | ENST00000245680 | - | 3 | 16 | 452_472 | 91 | 1176.3333333333333 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for SLC35F5-ACTR3 |
![]() |
>83024_83024_1_SLC35F5-ACTR3_SLC35F5_chr2_114512741_ENST00000409342_ACTR3_chr2_114697535_ENST00000263238_length(transcript)=6857nt_BP=999nt ATAGCTGACTGTGCCGTCCCTTCCCCTCACCCGCTCCACGCCCTCCTGGGCCGAGTGGAGTTGGGTGGTGTCGGGAGCCTCTCCCTGAGG GGCACCGCGTCTTCAGGAGCTGGGCCTCCAGTGCGGCGCGATGTCAGGCGCGGTGACAGCTCTGTGAGTCCGAGGCCGCGGCCGTGGCGC TGGGCGGCTGCGGGGCCTGACCGGTCCGCTCATGGTGCCGCCACGACGCCATCGCGGGGCAGGAAGGCCAGGTAGGCAGGCAGGGAAGGG CCCCGACATCACCGGAGCCCAAACCGGGACGGAGTGCCCACCAGCAGCACCACCTCCTGCCCTCGGTGGCAGCAGGAGCGCCTTGACCGA AACCGTGAAGGTCTCTAGGGGCGGAGGGAGCGGGAGCTGACAGGGGCGCCGGAGCCCTGCGCCCACCGCTGGCAATTGAGGAAGCCGTGC GTGCGCCCTCGCCTCGGCTCCCCGGGGAGGCGTCGCTGCCTTAACTGTCTTCCCCGCTCCAAAACAGAAGGATGATTTCTTTTCCCAGCT GTTTCTTTTAAAATGACTGGATGTTTTGATAGAGGTGGGTGGAGGAGCATGGAGAATCCTTTTCTTTTACCACTTGAAGAGATTGGAAAG GTGCCTTCAAGACCCACAGCAAATCACTTACTCTCCGATAACCAAATTCCACTCCAGCAGATCAGGGACAGAAAAGACACTTTTAGAAAC AGTGTCTAGACGCTGTCCCCAGGGATGGATTCCTCTGGATGGAGAGGGGTGCTGAGTTCTTCACCTCCTTTTAGACTGAGATCTGCCAAG TTTTCCGGCATTGCTCTTGAGGATCTCAGAAGGGCTCTTAAGACAAGACTGCAAATGGTGTGTGTATTTGTCATGAACCGAATGAATTCC CAGAACAGTGGTTTCACTCAGCGCAGGCGAATGGCTCTTGGGATTGTTATTCTTCTGCTTGTTGATGTGATATGGGTTGCTTCCTCTGAA CTTACTTCGGCTGAAGGGTATGTGATTGGCAGCTGTATTAAACACATTCCAATCGCAGGACGAGATATAACATATTTTATTCAGCAACTG CTGAGAGACCGAGAAGTAGGAATCCCTCCAGAACAATCCTTGGAAACTGCTAAGGCAGTAAAGGAGCGCTATAGTTATGTCTGCCCAGAT TTAGTAAAAGAATTTAACAAGTATGATACAGATGGGTCAAAATGGATTAAACAGTATACTGGAATCAATGCTATCTCAAAGAAAGAGTTT TCTATCGATGTTGGTTATGAGAGATTTTTGGGACCTGAAATCTTTTTTCATCCAGAGTTTGCTAATCCAGACTTTACACAACCTATCTCA GAAGTTGTAGATGAAGTAATTCAGAATTGTCCTATTGATGTCAGACGTCCTCTCTACAAGAATATTGTCCTCTCTGGAGGTTCAACCATG TTCAGGGACTTTGGACGTCGCTTGCAAAGAGATTTGAAAAGAACTGTAGATGCCCGGCTGAAATTAAGTGAGGAATTGAGTGGTGGTAGA TTGAAGCCAAAACCTATTGATGTACAAGTCATTACACACCACATGCAGCGATATGCAGTTTGGTTTGGAGGATCAATGCTGGCTTCCACG CCTGAGTTCTACCAAGTATGCCACACCAAAAAGGATTATGAAGAAATTGGACCTAGCATTTGTCGTCACAATCCAGTGTTTGGAGTCATG TCGTAAAATTGGCTTCATAGTTATTGGGGTTAGGGAGGTGGGGAAGAGATAATCTTTCTGATTACCTGTTTTGTCTGGATGGCTGGTTTT GAGGTTTTAAACCTGACTTGAAATAGTAACACCAAACATGATTATACAGGAATATTTTAATAAGTGTATCACCATGCAGATGTAGAAGAG AGCGAAAGTGATTGTGTTTTTCTTTAGATTGAATATTTGAATCTTATGTGTAACAAAAAGAAGTGGGTTTTAGTTCTTTCTGTGCCCTGA TATTTTGTATATTAATGAATTATCCAAGATTCGATGGGATTTATCAGTGTGTAGATAGCTCTATAATGCTTGAATTGTACACTTCTAAGT GTGCAGTGCAAGAGCTTGTTTATATTTCATACTTTTTATACTTTGAGGAAAAAAAGTCAAAGAAAAATTGTATTTGAGGGAAAAAACCAT GACCAAGTAAAGGATAAATTCAAAAAATAGCCTCATGAGACTTGGCATACACACTCGTGGGATTCCAGTTATTATGGAGTGCTTCCATCC CTCTCCACCCCTTCCCCCCAAAAGGTTTTCTTTGCAAGTGCTTTTGGAACTAAGAGCTAGTATCTTGGATTAACTGATGCCTGCTAGTGC TTTCTGATTACTCGCATTCTGTTTCTTGCTTTAAAAGAAGAGTAAAGACAAGAGTGTTGGACCAGTATTGCAGTTCTGTAGTGTCATTTC TTATAAAAAACAAAACAACAACAATAATTTATCAAAATTGGCATATTTAAAGCCTAACATTCTAATAAAGGCACAAATTTCTTTTTAATA CTTGTTTCAGCCTCTTTAATCTCTTTATAAGTTAACTAATAAATCTATTTTCTTCAGACTTCTGCAATAGTTCTTTAAAATCACAACAGT TAGCAAGCTGACTTTTGTAATGTGCTCAATACAAATACTTGTGAACTTTTAATATGTTGAGTGCTTTCATTTTGATAACTGGATCTCCAT TTGATATTTTCATTTGTATAACTCATTTGCAGTCTGAAAATTTTTTTTAGTGCCAGTCCCTGAACATATCATTGAAAGTTAATTTTCTTT GCATTTTAAAATATCTGGATTATGAAGAAAAAGTGATGAAAATAAATTAAAACTGAATTACCTTTTCTAATGTTTTTTTTTTTTAAGTAA TGTAATTCTATTTTGTTTTTATGTATGTGATATCTGTTTCTGTTGAGATTTGGGAGTTATTGAAATCTCTGTAATGTGTATGGTAGAAAA TTTCTTGTGACCTTAAAATTTTACCAGTTATTTATAGAAAGAGAAAATGGGAAATGTTTTATAGGCTTTTTACTAGCAGTATCAGTGAAC ACTTGAACTCCATTATTCATGAAAATAACACGTTAGGATTGGAATACGTCTATTCAAAAGTGAAAGAATATAAAGTGTTTAGTTTTTTGT TTTTACTCTAAAGATAGAATTGGGGAGTAAACTTCAGTTTTTGTTTAGAGTGGATCTGAATATTTAAAATCCTATAATAATTTTTGTGAA TCTTCATTCTTTGAGTATGGGATTGTAAAAGACAAACTATATCCTACAGTAGTATCATCATCAGTATCAAAGGTCTCCTTTTTTTACTTG GAAAAGTAATTCACAAACATTATAAAAATACTATTCAAACAGTACCAAAGAGTAGATTAGCAAAAGTAAGTTTTTTTCCCTAGCCTGTCT CATTTTTCCATCATTACACAGACTACTTGGAATGTCTTAGATGTCCTTGTATTGTAATTTTCTGTGTAGGTAGAAATAAATGTAGCTTTC TTATTTTACACAAATAGGAACTTACTGTATATACTGTTCTGCACTTTGCTTTTATTAAAGATCTTTTGATAAAGAACTATATTGATAAGC AGTAAAGATGTCATGCTCCTGGCCCAATAAAATATTGTTAGCATTGTCATAAATATGTCTTTTCCACCGGCGATGGTTGGGTAGTTAAGT GAATAAGCTAGAAAGACATGTTTATAAAGCTATTTGATGACAATCTCAGGCATATTTATACAGAGATGTTCTTAACTGTTTGCTACAAAA ACATGAAGATCAAAAACTTTCTTGAAGCTTACGCTTAACTTATTTGGGGAAACAAAACTCCAGCCCTTCTTGTGTATGTTCTGATATCCC TTTGCTCTACTTTTAGAGGAGTGAACCCTAATAGGATGGTAGCAGCATTCTTGTTTCTTTATATCTCTCCTCTGTGATTGTATACCGTTT TTTCAACTTAAAGCAACTTCAGCTGGAAATATGTAGAGGTTGGCCAAGGTGAACTAAATAGTCTGTAACATTGATTAGATATCAAGCAAC GTGAGCATGGTAGCAAAAGCACTAACTGAAGCCAGTGATTTAATTTTTAATTCTGATTCTGATAATTGATGATATAGCTCCTCGAACTTT GTTTTTTGTTAAAACTTGGAAAATATATTTGTATTATTTTGGACAAATTATTTGAACTCTCTGGACCTTGATTCAATTTATATATAAGGT AAAGGCATTATACTGGATTATCCTGCAATTTCTTTGAGTTGTTAGAATATAATGTAGCTTATTAATAGCAATATTAGCAGTGTAGTAGAT TCTGACTGCAAAACCTAGCCTTTTCTATTGATTCATTAGTGGTAGTAAAGGTATTATCTGATTTATCCTTTTTAATAGGCAGTGCTTTGA TCAAGTGGGAAATAGTAATGGACAAATAAAATCAATGATCATTATCTAACTTGATGCCTGCTTTTCAAAAAGTGAGCAAATTTCACATCT TCACCCTTAGACATTAATTCATGGCACCTACTATAAGTACTCATCCTCTTCTTACCTATCTTCTTTTCTATAGGAGATAAAGTGGTTATT CAGACCCCCCAATACAATTTTTTGGTTTGTTTTCACAGCTACTTAAAAGATTAAAATAACTATTCTTGCAGATATTTCTAGGAATATTTT TAGAAATAATATGAAATACAGGGATAATAGGCCAATTATGATCTTTATTTTTAATTTCTACAGAAAAGTACTAGAGAATATATCTATAGA AACTTCTTTCAGATAACCCTAAAGATGATACTAGAATGTTTATAAAATTATTGAGAAGATTATTTGTGTTATAAAGCTTATTTGTACCAT AGTAAAGGATGTTTTTGTTCCTCTTCATTCTGGGCTAATCTGTCAATACTGAAGTCCAGTCTTTTCCCCCTTTTCTTACCAGCTCAACCT TGATTCCTGTGACCCATTCTTTCTGATCTTTCGTAGTTCATAGTCACCAGGCATGAGTACCTTGGATAGCCCTCTGAAGTCTGTTACCAC CCAGATTTCCAACTCGGGTTAATTGGTACTAATTCTATTAGCTGGTATAAATAATCCAAAATCTGTGCAGACTCTGGGAGCAAAATGTTC TACTCAGTTTGGAATACTGTGCCTTAAAATATATTTCATTGTAACAGCACCTTGTATATATAGTTGGCCAAGGACAGAGTTGTTACAAGT TACGTGGAACTTTCATAGCAAATCTTGACAGTAAATACCTTGTTCTTGTATTAGGTCTATATCCTGAATTGACCTTTAGCAAGAATCTTT AGATCTGCTGGAGGGCTGGGATGGCTTTTGGACTTCAGTGAAAAAGAATTTCTGCTACTCATTGTTGATAACGCTTCAGTACTGTATAAA TGTTTATCCTTTTCCACGTAATTTGTTTTCTATGATATGAGAACTTTTATTATAATTTGCCTCAGTCTTGATAGAATCTTAACAAAAATA AAATCTGTGGTCGTCTGAGGTATTCTCCATGCTATAACCCAGTTTAGCTGATGCATTTGGAGCTTGGGTGCTGAAATTAAATATAACCTA TTTGAGTTAAGGATTTATTACTAGTGCTCCAGTGGTCACAGGAACAATAAAAAAGGAACAACGATAGAAATACGTGATCTAGGAAAGAAG GCAACTGAAAAACCTGAAAGAAAAAAAATGAAAGATTAAAAGTATACGATATTCTATTTTGATTTAGCAATTACTTGTTTTCTAGTGTTC TGTCAATTTTTGGTGACTTTTATAATTACATTAAAACTAAGATGCTGAATTAAAATAAAGTTTCTCTTTTATTCAAGCACCAACATTCAC TTATATTACCTATATATTGCATCAAGTTTTGAGCCTTCAATCCCAGAAGCATTGATTGACTGTCTACTGTGGTTCAAGTACTGTGCATAA AGATGAATAAATATTCTGTCCTTGGCTTAGTCTAATAGTAAAGGCACTCTTAGAGGAGGGACAAATATTTTGCCTAGATAAGATTTGAGA GATAGTAAGTGCGGAATTTCTCTTCATAAAAATGGTAGTGTTAGTTGTTTAGAGGGAGAAGTCCAGCTATGTAAGGTGAAAGTGGGGCTT ATAAAAGTGGATCTATTGTTTAAAAATTAGTACTTTGCTCCTAAAATTTTTACCTAAGTGTTACATCCAACAACAGATGAAAGTAATTCG ACAGTAGCATCTGCTTTATTCATTTCATATTTCCAGTGCCTGACATATTGCTTGGCATATAGTAGTTTAGTGGATGTGTTTGATGAATGA ATGAGTAAAAATTATTTTTCATGTTAAAATAAAACTTTGAATTACATGAGTATACAACTTTTGTTCCTTCAAAATACCCATATTTGTCAA ATATGACCGAATTACGACTTTTTTTCTGTTCCACTAGTTTCTACCTTAGAAGTGACATTCTGCGTAAGGTAGTGGGGGATTACTAAGTGA TCATGACTTTTCTGAAGCAGGTCTTAAATAATTATCTAAGCCTTCAGTCATTTCAAAATCTCTGTAGTGTAAATGATCACAGGCTCTAAA TCAGATTGTTGTACAAGGTAATTGACATGTCCTGAAATGTAACATTCAACATTAACAGTAGAAACAGGCCTCATTTCTCCCTCTGGCTTT TATTGATCAATTTTGATATTGTCCAGATCCCATGTTAAACCACTTGATTTAGAGATGACTTAATTCTAAACTTCCTCCATTTTTAATTAA TAAGATTCAAGGTTGCAGTAAATTGTTAATCTTATTTGGAATTATATTAGAAAGTCGATATCGGAATTGGAACCACACATCTTTTTCTTA >83024_83024_1_SLC35F5-ACTR3_SLC35F5_chr2_114512741_ENST00000409342_ACTR3_chr2_114697535_ENST00000263238_length(amino acids)=327AA_BP=89 MSPGMDSSGWRGVLSSSPPFRLRSAKFSGIALEDLRRALKTRLQMVCVFVMNRMNSQNSGFTQRRRMALGIVILLLVDVIWVASSELTSA EGYVIGSCIKHIPIAGRDITYFIQQLLRDREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDV GYERFLGPEIFFHPEFANPDFTQPISEVVDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPK -------------------------------------------------------------- >83024_83024_2_SLC35F5-ACTR3_SLC35F5_chr2_114512741_ENST00000409342_ACTR3_chr2_114697535_ENST00000535589_length(transcript)=1852nt_BP=999nt ATAGCTGACTGTGCCGTCCCTTCCCCTCACCCGCTCCACGCCCTCCTGGGCCGAGTGGAGTTGGGTGGTGTCGGGAGCCTCTCCCTGAGG GGCACCGCGTCTTCAGGAGCTGGGCCTCCAGTGCGGCGCGATGTCAGGCGCGGTGACAGCTCTGTGAGTCCGAGGCCGCGGCCGTGGCGC TGGGCGGCTGCGGGGCCTGACCGGTCCGCTCATGGTGCCGCCACGACGCCATCGCGGGGCAGGAAGGCCAGGTAGGCAGGCAGGGAAGGG CCCCGACATCACCGGAGCCCAAACCGGGACGGAGTGCCCACCAGCAGCACCACCTCCTGCCCTCGGTGGCAGCAGGAGCGCCTTGACCGA AACCGTGAAGGTCTCTAGGGGCGGAGGGAGCGGGAGCTGACAGGGGCGCCGGAGCCCTGCGCCCACCGCTGGCAATTGAGGAAGCCGTGC GTGCGCCCTCGCCTCGGCTCCCCGGGGAGGCGTCGCTGCCTTAACTGTCTTCCCCGCTCCAAAACAGAAGGATGATTTCTTTTCCCAGCT GTTTCTTTTAAAATGACTGGATGTTTTGATAGAGGTGGGTGGAGGAGCATGGAGAATCCTTTTCTTTTACCACTTGAAGAGATTGGAAAG GTGCCTTCAAGACCCACAGCAAATCACTTACTCTCCGATAACCAAATTCCACTCCAGCAGATCAGGGACAGAAAAGACACTTTTAGAAAC AGTGTCTAGACGCTGTCCCCAGGGATGGATTCCTCTGGATGGAGAGGGGTGCTGAGTTCTTCACCTCCTTTTAGACTGAGATCTGCCAAG TTTTCCGGCATTGCTCTTGAGGATCTCAGAAGGGCTCTTAAGACAAGACTGCAAATGGTGTGTGTATTTGTCATGAACCGAATGAATTCC CAGAACAGTGGTTTCACTCAGCGCAGGCGAATGGCTCTTGGGATTGTTATTCTTCTGCTTGTTGATGTGATATGGGTTGCTTCCTCTGAA CTTACTTCGGCTGAAGGGTATGTGATTGGCAGCTGTATTAAACACATTCCAATCGCAGGACGAGATATAACATATTTTATTCAGCAACTG CTGAGAGACCGAGAAGTAGGAATCCCTCCAGAACAATCCTTGGAAACTGCTAAGGCAGTAAAGGAGCGCTATAGTTATGTCTGCCCAGAT TTAGTAAAAGAATTTAACAAGTATGATACAGATGGGTCAAAATGGATTAAACAGTATACTGGAATCAATGCTATCTCAAAGAAAGAGTTT TCTATCGATGTTGGTTATGAGAGATTTTTGGGACCTGAAATCTTTTTTCATCCAGAGTTTGCTAATCCAGACTTTACACAACCTATCTCA GAAGTTGTAGATGAAGTAATTCAGAATTGTCCTATTGATGTCAGACGTCCTCTCTACAAGAATATTGTCCTCTCTGGAGGTTCAACCATG TTCAGGGACTTTGGACGTCGCTTGCAAAGAGATTTGAAAAGAACTGTAGATGCCCGGCTGAAATTAAGTGAGGAATTGAGTGGTGGTAGA TTGAAGCCAAAACCTATTGATGTACAAGTCATTACACACCACATGCAGCGATATGCAGTTTGGTTTGGAGGATCAATGCTGGCTTCCACG CCTGAGTTCTACCAAGTATGCCACACCAAAAAGGATTATGAAGAAATTGGACCTAGCATTTGTCGTCACAATCCAGTGTTTGGAGTCATG TCGTAAAATTGGCTTCATAGTTATTGGGGTTAGGGAGGTGGGGAAGAGATAATCTTTCTGATTACCTGTTTTGTCTGGATGGCTGGTTTT >83024_83024_2_SLC35F5-ACTR3_SLC35F5_chr2_114512741_ENST00000409342_ACTR3_chr2_114697535_ENST00000535589_length(amino acids)=327AA_BP=89 MSPGMDSSGWRGVLSSSPPFRLRSAKFSGIALEDLRRALKTRLQMVCVFVMNRMNSQNSGFTQRRRMALGIVILLLVDVIWVASSELTSA EGYVIGSCIKHIPIAGRDITYFIQQLLRDREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDV GYERFLGPEIFFHPEFANPDFTQPISEVVDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPK -------------------------------------------------------------- >83024_83024_3_SLC35F5-ACTR3_SLC35F5_chr2_114512741_ENST00000409342_ACTR3_chr2_114697535_ENST00000536059_length(transcript)=1831nt_BP=999nt ATAGCTGACTGTGCCGTCCCTTCCCCTCACCCGCTCCACGCCCTCCTGGGCCGAGTGGAGTTGGGTGGTGTCGGGAGCCTCTCCCTGAGG GGCACCGCGTCTTCAGGAGCTGGGCCTCCAGTGCGGCGCGATGTCAGGCGCGGTGACAGCTCTGTGAGTCCGAGGCCGCGGCCGTGGCGC TGGGCGGCTGCGGGGCCTGACCGGTCCGCTCATGGTGCCGCCACGACGCCATCGCGGGGCAGGAAGGCCAGGTAGGCAGGCAGGGAAGGG CCCCGACATCACCGGAGCCCAAACCGGGACGGAGTGCCCACCAGCAGCACCACCTCCTGCCCTCGGTGGCAGCAGGAGCGCCTTGACCGA AACCGTGAAGGTCTCTAGGGGCGGAGGGAGCGGGAGCTGACAGGGGCGCCGGAGCCCTGCGCCCACCGCTGGCAATTGAGGAAGCCGTGC GTGCGCCCTCGCCTCGGCTCCCCGGGGAGGCGTCGCTGCCTTAACTGTCTTCCCCGCTCCAAAACAGAAGGATGATTTCTTTTCCCAGCT GTTTCTTTTAAAATGACTGGATGTTTTGATAGAGGTGGGTGGAGGAGCATGGAGAATCCTTTTCTTTTACCACTTGAAGAGATTGGAAAG GTGCCTTCAAGACCCACAGCAAATCACTTACTCTCCGATAACCAAATTCCACTCCAGCAGATCAGGGACAGAAAAGACACTTTTAGAAAC AGTGTCTAGACGCTGTCCCCAGGGATGGATTCCTCTGGATGGAGAGGGGTGCTGAGTTCTTCACCTCCTTTTAGACTGAGATCTGCCAAG TTTTCCGGCATTGCTCTTGAGGATCTCAGAAGGGCTCTTAAGACAAGACTGCAAATGGTGTGTGTATTTGTCATGAACCGAATGAATTCC CAGAACAGTGGTTTCACTCAGCGCAGGCGAATGGCTCTTGGGATTGTTATTCTTCTGCTTGTTGATGTGATATGGGTTGCTTCCTCTGAA CTTACTTCGGCTGAAGGGTATGTGATTGGCAGCTGTATTAAACACATTCCAATCGCAGGACGAGATATAACATATTTTATTCAGCAACTG CTGAGAGACCGAGAAGTAGGAATCCCTCCAGAACAATCCTTGGAAACTGCTAAGGCAGTAAAGGAGCGCTATAGTTATGTCTGCCCAGAT TTAGTAAAAGAATTTAACAAGTATGATACAGATGGGTCAAAATGGATTAAACAGTATACTGGAATCAATGCTATCTCAAAGAAAGAGTTT TCTATCGATGTTGGTTATGAGAGATTTTTGGGACCTGAAATCTTTTTTCATCCAGAGTTTGCTAATCCAGACTTTACACAACCTATCTCA GAAGTTGTAGATGAAGTAATTCAGAATTGTCCTATTGATGTCAGACGTCCTCTCTACAAGAATATTGTCCTCTCTGGAGGTTCAACCATG TTCAGGGACTTTGGACGTCGCTTGCAAAGAGATTTGAAAAGAACTGTAGATGCCCGGCTGAAATTAAGTGAGGAATTGAGTGGTGGTAGA TTGAAGCCAAAACCTATTGATGTACAAGTCATTACACACCACATGCAGCGATATGCAGTTTGGTTTGGAGGATCAATGCTGGCTTCCACG CCTGAGTTCTACCAAGTATGCCACACCAAAAAGGATTATGAAGAAATTGGACCTAGCATTTGTCGTCACAATCCAGTGTTTGGAGTCATG TCGTAAAATTGGCTTCATAGTTATTGGGGTTAGGGAGGTGGGGAAGAGATAATCTTTCTGATTACCTGTTTTGTCTGGATGGCTGGTTTT >83024_83024_3_SLC35F5-ACTR3_SLC35F5_chr2_114512741_ENST00000409342_ACTR3_chr2_114697535_ENST00000536059_length(amino acids)=327AA_BP=89 MSPGMDSSGWRGVLSSSPPFRLRSAKFSGIALEDLRRALKTRLQMVCVFVMNRMNSQNSGFTQRRRMALGIVILLLVDVIWVASSELTSA EGYVIGSCIKHIPIAGRDITYFIQQLLRDREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDV GYERFLGPEIFFHPEFANPDFTQPISEVVDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for SLC35F5-ACTR3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SLC35F5-ACTR3 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SLC35F5-ACTR3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | C0019193 | Hepatitis, Toxic | 1 | CTD_human | |
Tgene | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human | |
Tgene | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human | |
Tgene | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human | |
Tgene | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human | |
Tgene | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |